Sg Americas Securities, LLC Silence Therapeutics PLC Transaction History
Sg Americas Securities, LLC
- $24.1 Billion
- Q2 2025
A detailed history of Sg Americas Securities, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Sg Americas Securities, LLC holds 308,331 shares of SLN stock, worth $1.72 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
308,331
Previous 308,289
0.01%
Holding current value
$1.72 Million
Previous $869,000
105.75%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SLN
# of Institutions
62Shares Held
21.8MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$17 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$16.3 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$12.4 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$11.2 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$10.3 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $201M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...